Spots Global Cancer Trial Database for pulmonary neoplasms
Every month we try and update this database with for pulmonary neoplasms cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Study of Preoperative Docetaxel or Cisplatin (CDDP) + Docetaxel for C-stage IB-II Non-Small Cell Lung Cancer (NSCLC) | NCT00132639 | Pulmonary Neopl... | Preoperative do... Preoperative do... | 20 Years - 74 Years | Japan Clinical Oncology Group | |
Identification of Prognostic Biomarkers for Progression of Invasive Squamous Cell Carcinoma | NCT02549638 | Carcinoma, Squa... Carcinoma, Squa... Squamous Cell C... Lung Neoplasms Cancer of Lung Cancer of the L... Lung Cancer Neoplasms, Lung Neoplasms, Pulm... Pulmonary Cance... Pulmonary Neopl... | DNA Extraction | 18 Years - | Mayo Clinic | |
Isolating and Testing Circulating Tumor DNA and Soluble Immune Markers During the Course of Treatment for Lung Cancer | NCT02410603 | Lung Cancer Lung Neoplasms Cancer of Lung Cancer of the L... Neoplasms, Lung Neoplasms, Pulm... Pulmonary Cance... Pulmonary Neopl... Carcinoma, Non-... Adenocarcinoma Squamous Cell C... | 18 Years - | Mayo Clinic | ||
A Study of Selpercatinib (LOXO-292) in Participants With Advanced Solid Tumors, RET Fusion-Positive Solid Tumors, and Medullary Thyroid Cancer (LIBRETTO-001) | NCT03157128 | Non-Small Cell ... Medullary Thyro... Colon Cancer Any Solid Tumor | LOXO-292 | 12 Years - | Eli Lilly and Company | |
A Phase I Study of iPS Cell Generation From Patients With COPD | NCT01860898 | Thoracic Diseas... Respiratory Tra... Cancer of Lung Cancer of the L... Lung Cancer Lung Diseases, ... COPD Pulmonary Emphy... Neoplasms, Lung Neoplasms, Pulm... Pulmonary Cance... Pulmonary Neopl... Carcinoma, Non-... Carcinoma, Smal... | Skin Biopsy | 18 Years - | Mayo Clinic | |
A Phase I Study of iPS Cell Generation From Patients With COPD | NCT01860898 | Thoracic Diseas... Respiratory Tra... Cancer of Lung Cancer of the L... Lung Cancer Lung Diseases, ... COPD Pulmonary Emphy... Neoplasms, Lung Neoplasms, Pulm... Pulmonary Cance... Pulmonary Neopl... Carcinoma, Non-... Carcinoma, Smal... | Skin Biopsy | 18 Years - | Mayo Clinic | |
Identification of Prognostic Biomarkers for Progression of Invasive Squamous Cell Carcinoma | NCT02549638 | Carcinoma, Squa... Carcinoma, Squa... Squamous Cell C... Lung Neoplasms Cancer of Lung Cancer of the L... Lung Cancer Neoplasms, Lung Neoplasms, Pulm... Pulmonary Cance... Pulmonary Neopl... | DNA Extraction | 18 Years - | Mayo Clinic | |
A Phase 2 Trial of Antisense Nucleotide to PKC-Alpha (LY900003, ISIS 3521) Plus Gemcitabine and Carboplatin in Patients With Advanced, Previously Untreated Non-Small Cell Lung Cancer. | NCT00042679 | Carcinoma, Non-... Pulmonary Neopl... Neoplasms, Lung | Gemcitabine Carboplatin LY900003 | 18 Years - | Eli Lilly and Company | |
A Phase 2 Trial of Antisense Nucleotide to PKC-Alpha (LY900003, ISIS 3521) Plus Gemcitabine and Carboplatin in Patients With Advanced, Previously Untreated Non-Small Cell Lung Cancer. | NCT00042679 | Carcinoma, Non-... Pulmonary Neopl... Neoplasms, Lung | Gemcitabine Carboplatin LY900003 | 18 Years - | Eli Lilly and Company | |
Bronchial Ultrasonography Via a Fibrescope: Pilot Study in Tumoral Disease | NCT00241267 | Pulmonary Neopl... | Dedicated ultra... | 18 Years - | University Hospital, Tours | |
Study of Preoperative Docetaxel or Cisplatin (CDDP) + Docetaxel for C-stage IB-II Non-Small Cell Lung Cancer (NSCLC) | NCT00132639 | Pulmonary Neopl... | Preoperative do... Preoperative do... | 20 Years - 74 Years | Japan Clinical Oncology Group | |
A Study to Isolate and Test Circulating Tumor Cells Using the ClearCell® FX EP+ System | NCT02370303 | Lung Cancer Lung Neoplasms Cancer of Lung Cancer of the L... Neoplasms, Lung Neoplasms, Pulm... Pulmonary Cance... Pulmonary Neopl... Carcinoma, Non-... Adenocarcinoma Squamous Cell C... | 18 Years - | Mayo Clinic | ||
A Study to Isolate and Test Circulating Tumor Cells Using the ClearCell® FX EP+ System | NCT02370303 | Lung Cancer Lung Neoplasms Cancer of Lung Cancer of the L... Neoplasms, Lung Neoplasms, Pulm... Pulmonary Cance... Pulmonary Neopl... Carcinoma, Non-... Adenocarcinoma Squamous Cell C... | 18 Years - | Mayo Clinic | ||
Breath Test for Early Detection of Lung Cancer | NCT00639067 | Lung Neoplasms | Breath Collecti... | 18 Years - | Menssana Research, Inc. | |
Protocol for Radiofrequency Ablation of Pulmonary Neoplasms | NCT00232128 | Pulmonary Neopl... | Radiofrequency ... | 19 Years - | Oncology Specialties, Alabama | |
A Study of Oral LOXO-292 (Selpercatinib) in Pediatric Participants With Advanced Solid or Primary Central Nervous System (CNS) Tumors | NCT03899792 | Medullary Thyro... Infantile Myofi... Infantile Fibro... Papillary Thyro... Soft Tissue Sar... | LOXO-292 | 6 Months - 21 Years | Eli Lilly and Company | |
Study of Arsenic Trioxide in Small Cell Lung Cancer | NCT01470248 | Lung Cancer Cancer of Lung Pulmonary Cance... Pulmonary Neopl... Carcinoma, Smal... | Arsenic Trioxid... | 18 Years - | Emory University | |
Bronchial Ultrasonography Via a Fibrescope: Pilot Study in Tumoral Disease | NCT00241267 | Pulmonary Neopl... | Dedicated ultra... | 18 Years - | University Hospital, Tours | |
A Study of Oral LOXO-292 (Selpercatinib) in Pediatric Participants With Advanced Solid or Primary Central Nervous System (CNS) Tumors | NCT03899792 | Medullary Thyro... Infantile Myofi... Infantile Fibro... Papillary Thyro... Soft Tissue Sar... | LOXO-292 | 6 Months - 21 Years | Eli Lilly and Company | |
MARK 1A Series: Percutaneous Microwave Ablation for Patients With Lung Tumor(s) | NCT02673021 | Lung Neoplasms Cancer of Lung Cancer of the L... Lung Cancer Neoplasms, Lung Neoplasms, Pulm... Pulmonary Cance... Pulmonary Neopl... Metastatic Canc... | Microwave ablat... | 18 Years - | Mayo Clinic | |
Breath Test for Early Detection of Lung Cancer | NCT00639067 | Lung Neoplasms | Breath Collecti... | 18 Years - | Menssana Research, Inc. | |
Study of Preoperative Docetaxel or Cisplatin (CDDP) + Docetaxel for C-stage IB-II Non-Small Cell Lung Cancer (NSCLC) | NCT00132639 | Pulmonary Neopl... | Preoperative do... Preoperative do... | 20 Years - 74 Years | Japan Clinical Oncology Group | |
Bronchial Ultrasonography Via a Fibrescope: Pilot Study in Tumoral Disease | NCT00241267 | Pulmonary Neopl... | Dedicated ultra... | 18 Years - | University Hospital, Tours | |
Study of JDQ443 in Patients With Advanced Solid Tumors Harboring the KRAS G12C Mutation | NCT04699188 | KRAS G12C Mutan... Carcinoma, Non-... Carcinoma, Colo... Cancer of Lung Cancer of the L... Lung Cancer Neoplasms, Lung Neoplasms, Pulm... Pulmonary Cance... Pulmonary Neopl... | JDQ443 TNO155 tislelizumab | 18 Years - | Novartis | |
A Case-Control Study to Verify Diagnostic Performance of AminoIndex™ Technology | NCT02512757 | Lung Cancer | 18 Years - 79 Years | Innovis LLC |